COMPANY

Ancora Heart

HQ: Santa Clara, CA source · ancoraheart.com ↗ · West Coast

Ancora Heart is listed on ClinicalTrials.gov as the lead sponsor of 9 studies; the most recently updated is “Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study” (no phase, suspended), in Heart Failure With Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy. From public records Source · Oct 12, 2026

Keywords: heart failure Dilated Cardiomyopathy Mitral Valve Insufficiency Cardiomyopathies Functional Mitral Regurgitation Heart Failure With Reduced Ejection Fraction Mitral Regurgitation Mitral Valve Regurgitation Severe Functional Mitral Regurgitation and Heart Failure AccuCinch® Ventriculoplasty System Mitral valve repair Left ventricular restoration Accucinch Implant GDS Accucinch System

Location: Santa Clara, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

9Trials (company is sponsor)

Timeline

Dec 21, 2020 Trial start Not phased (device or behavioral study): Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study source ↗
Jan 15, 2019 Trial start Not phased (device or behavioral study): Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study source ↗
Sep 24, 2018 Trial start Not phased (device or behavioral study): Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation source ↗
Aug 23, 2018 Trial start Not phased (device or behavioral study): Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction source ↗
2016-09 Trial start Not phased (device or behavioral study): Safety and Performance of the AccuCinch® System source ↗
2016-08 Trial start Not phased (device or behavioral study): The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study source ↗
2014-08 Trial start Not phased (device or behavioral study): Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function source ↗
2013-10 Trial start Not phased (device or behavioral study): Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function source ↗
2008-11 Trial start Not phased (device or behavioral study): A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study source ↗

Upcoming milestones

Oct 31, 2026 (ESTIMATED) · Not phased · Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study · NCT03183895

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 9

Record	Title	Phase	Status	Start	Primary completion
NCT04331769	Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study	Not phased (device or behavioral study)	Suspended	Dec 21, 2020	Dec 31, 2026 (estimated)
NCT03533517	Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction	Not phased (device or behavioral study)	Active, not recruiting	Aug 23, 2018	Mar 26, 2021 (actual)
NCT02806570	The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study	Not phased (device or behavioral study)	Completed	2016-08	2020-01 (actual)
NCT03183895	Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study	Not phased (device or behavioral study)	Active, not recruiting	Jan 15, 2019	Oct 31, 2026 (estimated)
NCT03560167	Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation	Not phased (device or behavioral study)	Completed	Sep 24, 2018	Mar 25, 2021 (actual)
NCT00800046	A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study	Not phased (device or behavioral study)	Completed	2008-11	2020-11 (actual)
NCT02624960	Safety and Performance of the AccuCinch® System	Not phased (device or behavioral study)	Withdrawn	2016-09	2019-03 (estimated)
NCT02153892	Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function	Not phased (device or behavioral study)	Completed	2014-08	2015-10 (actual)
NCT01899573	Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function	Not phased (device or behavioral study)	Completed	2013-10	2016-01 (actual)